NCT01415427
MPS IVA, Mucopolysaccharidosis IV A, Morquio A Syndrome
The below information is taken directly from public registry websites such as ClinicalTrials.gov, EuClinicalTrials.eu, ISRCTN.com, etc. and has not been edited.
This Phase 3 extension study will evaluate the long-term efficacy and safety of BMN 110 2.0 mg/kg/week and/or BMN 110 2.0 mg/kg/every other week in patients with mucopolysaccharidosis IVA (Morquio A Syndrome).
All
From 5 Years
No
BMN 110 - Weekly, BMN 110 - Every Other Week
Phase 3
Interventional
173
2011-07
2021-07-21
Phoenix, Arizona, United States
Oakland, California, United States
Orange, California, United States
Wilmington, Delaware, United States
Washington, District of Columbia, United States
Orlando, Florida, United States
Honolulu, Hawaii, United States
Chicago, Illinois, United States
New York, New York, United States
Seattle, Washington, United States
Cordoba, , Argentina
Campina Grande, , Brazil
Porto Alegre, , Brazil
Rio de Janeiro, , Brazil
Montreal, , Canada
Sherbrooke, , Canada
Toronto, , Canada
Bogota, , Colombia
Copenhagen, , Denmark
Lyon, , France
Marseille, , France
Paris, , France
Paris, , France
Mainz, , Germany
Monza, , Italy
Tokyo, , Japan
Seoul, , Korea, Republic of
Amsterdam, , Netherlands
Oslo, , Norway
Coimbra, , Portugal
Lisbon, , Portugal
Doha, , Qatar
Riyadh, , Saudi Arabia
Santiago de Compostela, , Spain
Taipei, , Taiwan
Ankara, , Turkey
Belfast, , United Kingdom
Birmingham, , United Kingdom
Birmingham, , United Kingdom
London, , United Kingdom
London, , United Kingdom
London, , United Kingdom
Manchester, , United Kingdom
By completing this form and clicking the send button, you understand and hereby consent to storage of your personal information, including within the United States and Europe, which will be accessible by BioMarin for purposes such as responding to your request, quality control, fulfilling compliance obligations, and assisting with products, services, or clinical trials. Depending on where you live, you may have the right to request access to, removal, or correction of your personal information held by BioMarin. You may submit your request via the contact information and/or webform located within the full BioMarin Privacy Policy.
*required fields
"*" indicates required fields